Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.38 | 1.42 |
NAV | ₹17.80 | ₹1786.83 |
Fund Started | 14 Jan 2008 | 08 Dec 1994 |
Fund Size | ₹227.74 Cr | ₹65966.82 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 0.77% | 12.61% |
3 Year | 15.36% | 21.49% |
5 Year | 12.98% | 22.41% |
1 Year
3 Year
5 Year
Equity | 97.20% | 87.74% |
Cash | 2.80% | 11.48% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Infosys Ltd. | 6.61% |
Bajaj Finance Ltd. | 6.23% |
Titan Company Ltd. | 5.53% |
ICICI Bank Ltd. | 5.10% |
HDFC Bank Ltd. | 4.92% |
Interglobe Aviation Ltd. | 4.75% |
Maruti Suzuki India Ltd. | 4.59% |
Bharti Airtel Ltd. | 4.28% |
PB Fintech Ltd. | 4.00% |
Swiggy Ltd. | 3.65% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.40% |
HDFC Bank Ltd. | 9.27% |
Axis Bank Ltd. | 8.37% |
Kotak Mahindra Bank Ltd. | 4.76% |
Maruti Suzuki India Ltd. | 4.67% |
SBI Life Insurance Company Ltd. | 4.39% |
Cipla Ltd. | 4.31% |
Bharti Airtel Ltd. | 3.99% |
HCL Technologies Ltd. | 3.14% |
Piramal Pharma Ltd. | 2.67% |
Name | Satish Ramanathan | Dhruv Muchhal |
Start Date | 01 Oct 2024 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation/income by investing in equity and equity related instruments across market capitalization of up to 30 companies. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 14 Jan 2008 | 08 Dec 1994 |
Description
Launch Date